Untapped potential and huge profits: An unprecedented fund with a global presence Israelis led by an expert female general partner and targets untapped opportunities in women's health. Europe, united states of americaand Israel.
Tel Aviv, Israel, April 9, 2024 /PRNewswire/ — We are pleased to announce the successful first close of KIDRON Capital Assets, a significant milestone as the premier venture capital fund focused on women's health. Led by her two female general partners with deep investment and industry expertise in health tech, KIDRON is uniquely positioned at the intersection of breakthrough healthcare innovation and untapped investment potential. I am. Our primary mission is to leverage the broad yet often overlooked opportunities in women's health to generate superior returns for our investors.
Our investment scope is Europe, united states of americaand Israel. KIDRON's portfolio includes a variety of sectors including medical devices, diagnostics, digital health, therapeutics and services. This strategic diversity ensures our ability to impact multiple aspects of women's health while driving innovation, positive change and superior returns for our investors.
The fund has made first-time investments in ground-breaking U.S.-based companies, all of which are poised to generate significant returns.
- beyond medicine: Pioneering the field of longevity with cutting-edge solutions that redefine human healthspan by targeting mitochondrial health, improving skin rejuvenation and reducing menopausal symptoms.
- Portal: start a revolution 1 billion dollars Backed by a proven team with six exits to giants such as Medtronic and BD, Portal's approach to market with simplified, scalable solutions for oncology clinics faces cancer. It suggests a strong potential to improve women's access to care and quality of life, and generate returns for investors.
- kidney guard: The only clinically validated solution to prevent acute kidney injury (AKI), which women are at increased risk of during cardiac surgery. With CE approval, early sales, and research in the U.S., Renal Guard redefines the standard of care and promises significant returns for investors while ensuring the health and safety of women during common surgical procedures. .
Invest in the future of women's health: Partner with KIDRON Capital to generate high returns and make a difference.
For more information, please visit https://kidron-capital.com/.
For media inquiries or further information, please contact:
Maria Gajda Horowitz
Founder and Managing Partner
[email protected]
Mobile: +972 (0) 505-983-766
Logo – https://mm.prnewswire.com/media/2381618/Kidron_Capital_Assets_Logo.jpg
Source Kidron Capital Assets
